Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

BACKGROUND/AIMS: The success of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) has focused interest on the role of Ras signaling in this malignancy. We investigated the molecular alterations of the Ras pathway in HCC and the antineoplastic effects of sorafenib in combination w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Newell, Pippa, Toffanin, Sara, Villanueva, Augusto, Chiang, Derek Y., Minguez, Beatriz, Cabellos, Laia, Savic, Radoslav, Hoshida, Yujin, Lim, Kiat Hon, Melgar-Lesmes, Pedro, Yea, Steven, Peix, Judit, Deniz, Kemal, Fiel, M. Isabel, Thung, Swan, Alsinet, Clara, Tovar, Victoria, Mazzaferro, Vincenzo, Bruix, Jordi, Roayaie, Sasan, Schwartz, Myron, Friedman, Scott L., Llovet, Josep M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2009
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2970800/
https://ncbi.nlm.nih.gov/pubmed/19665249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2009.03.028
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk